Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 18, 16:00
Akero Therapeutics Gross Profit (TTM): -0.015M for Sept. 30, 2025
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Pfizer Inc. | 43.40B |
| Eli Lilly & Co. | 49.34B |
| Bristol Myers Squibb Co. | 30.90B |
| Johnson & Johnson | 62.91B |
| Adaptive Biotechnologies Corp. | 169.88M |